Fundraising FoxDroia Ventures — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Montis Biosciencesmontisbiosciences.cominFeb 2020✓ verified
Montis Biosciences is a biotechnology company developing anti-C1q antibodies that target both the complement and myeloid axes to treat neuroinflammatory, autoimmune, neurodegenerative and ophthalmic diseases, with a lead program in Guillain-Barré syndrome.
BiotechHealthtechLeuven, BE
Federico Grossi(Clinical Advisor & Acting CMO)
Co-investorsPfizer VenturesVIBPfizer Venture Investments
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.